Aims. To develop a low volume in vitro model with increased throughput simulating the human 25 small intestine, incorporating the presence of ileal microbiota, to study microbial behaviour in the 26 small intestine. 27
Introduction 44
There is a strong interest in finding efficient ways to investigate the behaviour of drugs, 45 foodstuffs, bioactives and probiotics in the gastrointestinal tract. Probiotics are live 46 microorganisms that when ingested in appropriate amounts have beneficial effects on host-health (Hill et al., 2014a) . Recent findings suggest that certain strains have a positive impact on e.g. physiological aspects of the GIT, in vivo models have several disadvantages. To tackle them, a 70 variety of in vitro models of the upper as well as the lower gastrointestinal tract (GIT) have been 71 developed. These models chiefly fall in two groups according to sample movement, namely static 72 models and dynamic models (Venema & Van den Abbeele, 2013; Guerra et al., 2012; Hur et al., 73 2011) . 74
Static models are based on a single reactor where the pH is usually fixed during the simulation 75 (pH 1-3 for stomach and pH 6-7 in the small intestinal phase). There are no dynamic changes of 76 pH along the process and gastric emptying or absorption are not mimicked. Static models are 77 useful for screening large number of samples, but they are also very much simplified and are 78 targeted to specific applications. Many different protocols are also in use, making comparison of 79 results between research groups challenging. To tackle this problem an INFOGEST working 80 group recently published a standardised static in vitro digestion protocol (Minekus et al., 2014) , 81
which is now widely used. 82
The most complex in vitro models reproduce processes occurring in the small intestine such as 83 bile salts and small nutrient absorption, dynamic changes of pH, reproduction and simulation of 84 enzymes secretion rates and realistic transit times (Table 1) . All existing models operate with 85 relatively large volumes, and thus require large amounts of sample material for testing, which 86 can lead to high experimental costs. A relatively low throughput (up to two replicates per 87 experiment) makes it challenging to obtain enough repetitions to infer statistical differences 88 between treatments. None of the existing models mimic the small intestinal microbiota, even 89 though recent findings indicate that especially the ileal microbiota plays an important role in the 90 metabolism of nutrients and influences absorption of bioactives (El-Aidy et al., 2015) as well as 91 in short oligosaccharide and plant cell wall polysaccharide degradation, carbohydrate uptake and 92 energy metabolism (Patrascu et al., 2017; Zoetendal et al., 2012) . Further, SI microbiota 93 dysbiosis is associated with diseases like small bowel bacteria overgrowth (SIBO) (Bures et al., 94 2010), celiac disease (Collado et al., 2009; Ou et al., 2009 ) and inflammatory bowel disease 95 (IBD) (Booijink et al., 2010; Willing et al., 2009 ). Probiotics and prebiotics might be an 96 attractive way to lower the risk of some SI diseases and could be used as an alternative for 97 antibiotic treatment with their acute side effects by restoring a predominance of beneficial 98 microbes (Ducatelle et al., 2015; Sartor, 2004) . Therefore the addition of a small intestine 99 microbiota to an in vitro SI model might offer a valuable tool for studying the interplay between 100 probiotics, prebiotics, SI microbiota and bioavailability of bioactives. 101
The aim of the present study was to develop a small volume in vitro model of the human SI 102 (duodenum, jejunum and ileum) with increased throughput as a screening platform for studying 103 microbial behaviour during small intestinal passage. 104
The Smallest Intestine in vitro model 126
The Smallest Intestine in vitro model (TSI) simulates the passage through the human small 127 intestine by an adjustment of pH and concentration of bile salts, pancreatic enzymes and dialysis 128 to mimic absorption. Each TSI unit consist of 5 reactors, each with a working volume of 12 ml. 129 A stock of 80 g l -1 was prepared and the exact concentration of bile salts was determined using a 175 commercially available kit (Total Bile Acids Assay, Diazyme). To simulate conditions after 176 ingestion of a meal, "fed state" was mimicked by the presence of 10 mM bile salts in the reactor 177 and with addition of 1.4 ml of food replacement (Nutrison Energy Multi Fibre, Nutricia) as a 178 source of nutrients. Small intestinal passage without the presence of food components was 179 simulated by a "fasted state" by presence of 4 mM bile acids and 1.4 ml of water. 180
Finally, pH was adjusted (by syringe) to 6.5 by titrating with 1 M NaOH. During the duodenal 181 passage (2 hours) pH was elevated from 6.5 to 6.8 in steady increments (Fig 3) . Next, the 182 absorption of small nutrients and bile salts in the jejunum was simulated by continuously 183 pumping the samples through the dialysis chambers with a 10 kDa membrane cut-off at a pumping rate of 2.64 ml min -1 for 4 hours, as specified above. During the 4 hour simulation of 185 the jejunal passage pH was increased from 6.8 to 7.2. To simulate ileum, fresh SIF with a pH of 186 7.2 was added to the reactor to obtain a chyme to SIF ratio of 50:40 (v/v). Moreover 1 ml of 187 small intestine microbiota inoculum (Table 2 ) was added. The inoculum was adjusted to obtain 188 10 7 CFU ml -1 in the reactor. During simulated ileal passage (2 hours) pH was kept constant at 7.2. 189
The amount of base used to control pH was constantly recorded in order to compare inter and 190 intra-variability between samples and experimental conditions. After 8 hours of small intestine 191 passage samples were taken to check the concentration of bile salts. 192
193
Flow cytometry analysis of probiotic resistance towards bile salts 194
The response of the probiotic strains (Table 2) to bile was first assessed using flow cytometry 195 (FCM). Each bacterium was inoculated in 10 ml MRS broth medium and cultured for 24 hours. 196 Cells were harvested by centrifugation (10,000 g for 2 min) after which the supernatant was 197 discarded and the pellet re-suspended in 10 ml phosphate buffered saline (pH 7.4). The microbes 198 were then exposed to three different concentrations of the bile salts (10 mM, 4 mM and 1 mM) 199 by mixing 0.1 ml of inoculum with 0.9 ml of bile solution. Each probiotic strain (Table 2) was inoculated in 10 ml MRS broth medium and cultured for 24 211 hours. Cells were harvested by centrifugation (10,000 g for 2 min) after which the supernatant 212 was discarded and the pellets re-suspended in 10 ml of phosphate buffered saline (pH 7.4). Four 213 reactors were inoculated with 0.5 ml of bacterial solution, while the fifth was kept as a control to 214 check if there is a contamination in any of the compartments used along the experiment. Survival 215 was evaluated after 8 hours of simulated digestion via colony plate counts on MRS agar medium 216 (37°C, 24 hours incubations at anaerobic conditions) after serial dilution using a saline solution 217 (0.9% NaCl in water). Experiments were conducted separately for each probiotic strain and two 218 different feeding conditions in triplicates. Moreover the influence of ileal microbiota presence on 219 survival of probiotic strains in the small intestine was investigated by comparison of probiotic 220 survival with and without the presence of a small intestine microbial consortium. amount of alkali used to maintain pH during the experiment, according to probiotic strains and 256 feeding conditions, was monitored. There was no relationship between volume of sodium 257
hydroxide used and probiotic strain tested (data not shown). On the other hand, base 258 consumption correlated with feeding conditions. On average during fed state 717.44 ± 35.00 µl 259 of base was used versus 564.44 ± 22.90 µl in fasted state (p = 0.05). The bile salts concentration 260 was measured at the beginning and at the end of the experiment in each of the reactors. On 261 average the initial amount of bile salts was lowered by 61.98 ± 1.58 % (n = 36; data not shown). 262
There was no significant influence of feeding conditions and probiotic bacteria presence on bile 263 salts absorption (p = 0.34). 264 265
Bile salts resistance of probiotic strains 266
Bile salt resistance of the included probiotic strains was initially assessed using flow cytometry 267 (Table 3) Gastric conditions can be simulated in TSI model in both "fasted" (i.e. after ingestion of a glass 279 of water) and "fed" state (after ingestion of food). Persistence of the three probiotic strains was 280 inspected during the passage through the simplified gastric compartment (Table 4 ). In fed 281 conditions (pH 4, t = 120 min) all strains showed good survival, without any significant changes 282 in number of live cells. To elucidate dynamics of probiotic survival in fasted conditions (pH 2, t 283 = 60 min), samples were taken every 20 min for 1 hour. L. plantarum LP80 was the most 284 susceptible bacterium towards fasted gastric conditions. The number of cultivable cells went 285 below detection limit already after 20 minutes. Survival of L. casei Z11 was good during the first 286 20 min of experiment where the number of cultivable cells did not change significantly (Table 4 , 287 P = 0.07). At the second sampling point after 40 min, the number of cultivable cells went below 288 detection limit. The number of cultivable L. rhamnosus GG cells went down with time more 289 gradually (Table 4) . 290 291
Probiotic bacteria survival during the small intestine simulation 292
The survival of the three probiotic strains was tested in TSI model in two different feeding 293 conditions: conditions mimicking a "fasted" small intestine (i.e. before food ingestion; bile salts 294 = 4mM; pancreatic juice = 40 U ml -1 ) and a "fed" small intestine (i.e. after a meal; bile salts = 10 295 mM; pancreatic juice = 100 U ml -1 ). The influence of the small intestinal microbiota consortium 296 was tested in both feeding states (Fig 4) . Lactobacillus plantarum LP80, which is bile salt 297 hydrolase positive, showed good survival in both feeding conditions without the presence of the 298 small intestine microbiota ( deviates somewhat from the target value at the beginning of the jejunum stage. Along with 328 diffusion of small nutrients and bile salts there was a small volume of dialysis fluid getting into 329 the cassette, caused by osmotic pressure. The fluid had a pH higher than the sample in the 330 chamber, therefore the pH slightly increased initially due to the asymmetric pH control. 331
However, pH was rapidly normalised back to the target value (Fig 3) . . This is a unique characteristic of TSI, being the first in vitro model to 342 incorporate or mimic small intestine microbiota. The chosen strains were all of human origin and had to be resistant towards bile acids as the bile acid concentration at the beginning of the ileal 344 stage is still relatively high. An advantage of the defined consortium based on culture collection 345 strains, compared to e.g. a faecal inoculum, is that while fecal inoculum sooner or later will be 346 exhausted, the defined inoculum can always be reconstituted. Moreover, faecal samples are not 347 necessarily a good representation of small intestine microbiota (Chung et al., 2015) . The small 348 intestine is the place where food components during digestion encounter microbes in higher 349 numbers for the first time after ingestion. It also characterised by high transit speed (Yu et al., 350 1996; Yu & Amidon, 1998) . Therefore the ileum microbiota is specialised in fast uptake and 351 conversion of relatively simple carbohydrates, in contrast to the colonic microbiota which is 352 efficient in the degradation of complex carbohydrates (Zoetendal et al., 2012) . the main limiting factor being the low pH in the stomach (Morelli, 2000; Kailasapathy, 2006) . 358
The persistence of probiotic bacteria depends strongly on feeding conditions and the pH. In 359 experiments simulating the stomach in fed state with elevated pH and presence of nutrients all 360 three strains survive perfectly. These results are in line with previous studies showing that 361 addition of nutrients significantly improves survival of L. rhamnosus GG (Corcoran et al., 2005) . 362
In the fasted state, the tested bacteria showed diverse survival, but none of them manages to 363 thrive 60 minutes at pH 2. These results are comparable to previously published studies, where 364 number of cultivable cells goes below detection level within the first 40 min of the incubation 365 Detailed studies on probiotics survival in the human small intestine are scarce due to difficulties 367 with material sampling and ethical constrains. To address this issue, the TSI in vitro model was 368 developed and applied to determine probiotic survival by simulating conditions resembling 369 various sections of the human small intestine (duodenum, jejunum and ileum), in both "fed" and 370 "fasted" conditions, with and without the presence of simulated ileal microbiota. The three tested 371 probiotics strains exhibit diverse resistance towards SI conditions. Lactobacillus plantarum LP80 372 survived well, even at a high concentration of bile salts (Fig 4) . This was expected as this strain This effect is more pronounced in "fasted" reactors, due to lower concentration of bile salts and 387 higher probiotic survival rate. 388
The in vitro model of the small intestine presented in this study has a potential to become a 389 screening platform for modelling microbial survival during the passage of the human small 390 intestine. Thanks to affordable and exchangeable reactors and peripheries the TSI model can be 391 applied for testing pathogenic and spore forming bacteria. The TSI model can also potentially be 392 used in the future for studying behaviour of bacteriophages and effectiveness of probiotics and 393 enzymes microencapsulation formulations. 394
All in all the TSI represents a novel small intestinal in vitro model, that will be particularly useful 395 for screening purposes, where it is desirable to work with relatively small volumes and/or when 396 the small intestinal microbiota needs to be taken into the equation, and/or when assessing small 397 intestinal passage of microbes or enzymes. 
